EAACI Biologicals Guidelines—Omalizumab for the treatment of chronic spontaneous urticaria in adults and in the paediatric population 12–17 years old

Ioana Agache, Cezmi A Akdis, Mubeccel Akdis, Knut Brockow, Tomas Chivato, Stefano Giacco, Thomas Eiwegger, Kilian Eyerich, Ana Giménez‐arnau, Jan Gutermuth, Emma Guttman‐yassky, Marcus Maurer, Graham Ogg, Peck Y. Ong, Liam O’mahony, Jürgen Schwarze, Amena Warner, Thomas Werfel, Oscar Palomares, Marek Jutel

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'EAACI Biologicals Guidelines—Omalizumab for the treatment of chronic spontaneous urticaria in adults and in the paediatric population 12–17 years old'. Together they form a unique fingerprint.

Medicine & Life Sciences